130 related articles for article (PubMed ID: 23046435)
1. Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T
J Ocul Pharmacol Ther; 2013 Apr; 29(3):363-5. PubMed ID: 23046435
[TBL] [Abstract][Full Text] [Related]
2. Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion.
Park SP; Ahn JK
Clin Exp Ophthalmol; 2009 Jul; 37(5):490-5. PubMed ID: 19624346
[TBL] [Abstract][Full Text] [Related]
3. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
4. Association of inflammatory factors with macular edema in branch retinal vein occlusion.
Noma H; Mimura T; Eguchi S
JAMA Ophthalmol; 2013 Feb; 131(2):160-5. PubMed ID: 23411880
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
7. Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells.
Tong JP; Lam DS; Chan WM; Choy KW; Chan KP; Pang CP
Mol Vis; 2006 Dec; 12():1490-5. PubMed ID: 17167405
[TBL] [Abstract][Full Text] [Related]
8. Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion.
Park SP; Ahn JK
Clin Exp Ophthalmol; 2008 Dec; 36(9):831-5. PubMed ID: 19278477
[TBL] [Abstract][Full Text] [Related]
9. Effect of intravitreal anti-vascular endothelial growth factor treatment on the retinal gene expression in acute experimental central retinal vein occlusion.
Drechsler F; Köferl P; Hollborn M; Wiedemann P; Bringmann A; Kohen L; Rehak M
Ophthalmic Res; 2012; 47(3):157-62. PubMed ID: 22116547
[TBL] [Abstract][Full Text] [Related]
10. Influence of vitreous factors after vitrectomy for macular edema in patients with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K
Int Ophthalmol; 2011 Oct; 31(5):393-402. PubMed ID: 22105941
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
Patel PJ; Zaheer I; Karia N
Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion.
Fan C; Wang Y; Ji Q; Zhao B; Xie J
Curr Eye Res; 2014 Sep; 39(9):938-43. PubMed ID: 24635755
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
14. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion.
Park SP; Ahn JK; Mun GH
Retina; 2010 Feb; 30(2):281-6. PubMed ID: 19881397
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory factors in major and macular branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K
Ophthalmologica; 2012; 227(3):146-52. PubMed ID: 22269605
[TBL] [Abstract][Full Text] [Related]
16. Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion.
Kunikata H; Shimura M; Nakazawa T; Sonoda KH; Yoshimura T; Ishibashi T; Nishida K
Acta Ophthalmol; 2012 Mar; 90(2):162-7. PubMed ID: 20456252
[TBL] [Abstract][Full Text] [Related]
17. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
[TBL] [Abstract][Full Text] [Related]
18. Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma.
Wang JW; Zhou MW; Zhang X; Huang WB; Gao XB; Wang W; Chen S; Zhang XY; Ding XY; Jonas JB
Clin Exp Ophthalmol; 2015 Jul; 43(5):415-21. PubMed ID: 25488632
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation.
Costagliola C; Semeraro F; dell'Omo R; Romano MR; Russo A; Aceto F; Mastropasqua R; Porcellini A
Br J Ophthalmol; 2015 Jul; 99(7):1004-8. PubMed ID: 25770144
[TBL] [Abstract][Full Text] [Related]
20. THE OMAR STUDY: Comparison of Ozurdex and Triamcinolone Acetonide for Refractory Cystoid Macular Edema in Retinal Vein Occlusion.
Ozkok A; Saleh OA; Sigford DK; Heroman JW; Schaal S
Retina; 2015 Jul; 35(7):1393-400. PubMed ID: 25748280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
